reported that CCNE1 and CCNE2 can be used as therapeutic targets for non-small cell lung cancer, and BMMSCs-Exo carrying miR-144 could target CCNE1 and CCNE2. Here, CCNE1 is linked to non-small cell lung carcinoma.